DrugPatentWatch Database Preview
Amgen Company Profile
» See Plans and Pricing
US Patents for Amgen
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Amgen Inc | RIABNI | rituximab-arrx | INJECTABLE;INJECTION | 761140 | 001 | 2020-12-17 | RX | |||||
Amgen Inc | AVSOLA | infliximab-axxq | INJECTABLE;INJECTION | 761086 | 001 | 2019-12-06 | RX | |||||
Amgen Inc | AIMOVIG | erenumab-aooe | INJECTABLE;INJECTION | 761077 | 001 | 2019-03-11 | RX | |||||
Amgen Inc | KANJINTI | trastuzumab-anns | VIAL;SINGLE-DOSE | 761073 | 002 | 2019-10-25 | RX | |||||
Amgen Inc | KANJINTI | trastuzumab-anns | VIAL; MULTIDOSE | 761073 | 001 | 2019-10-25 | RX | |||||
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Similar Applicant Names
This search can help find similar names.